Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 22.90
+0.05 (0.22%)
Oct 20, 2026, 1:30 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 4.74 billion as of October 20, 2026. It is the 22,742nd most valuable company in the world and the 1,136th biggest in Taiwan. Its market cap has decreased by 35.15% in one year.
Market Cap
4.74B
Enterprise Value
5.60B
Revenue
815.87M
Global Rank
Country Rank
#1,136 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 4.74B, an increase of 711.72%. That is a compound annual growth rate of 12.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 4.74B | -27.59% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 6.38B |
| Sinphar Pharmaceutical | 6.30B |
| Medigen Biotechnology | 4.95B |
| BRIM Biotechnology | 4.47B |
| UnicoCell Biomed | 4.43B |
| Sunhawk Vision Biotech | 4.36B |
| Sinew Pharma | 4.26B |
| Formosa Pharmaceuticals | 3.83B |